Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst Matthew Sykes downgraded the rating for Charles River Laboratories International, Inc. CRL from Buy to Neutral and lowered the price target from $190 to $170. Charles River shares closed at $165.35 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Matthew Caufield downgraded OptiNose, Inc. OPTN from Buy to Neutral and lowered the price target from $18 to $9. OptiNose shares closed at $9.15 on Thursday. See how other analysts view this stock.
- Loop Capital analyst Rick Paterson downgraded the rating for FedEx Corporation FDX from Hold to Sell and lowered the price target from $283 to $221. FedEx shares closed at $246.21 on Thursday. See how other analysts view this stock.
- William Blair analyst Brian Drab downgraded the rating for Valmont Industries, Inc. VMI from Outperform to Market Perform. Valmont Industries shares closed at $326.58 on Thursday. See how other analysts view this stock.
- Wells Fargo analyst Jason Haas downgraded FactSet Research Systems Inc. FDS from Equal-Weight to Underweight and slashed the price target from $450 to $402. FactSet Research shares closed at $430.93 on Thursday. See how other analysts view this stock.
Considering buying FDX stock? Here’s what analysts think:
Today's Best Finance Deals
Read This Next:
Photo: Shutterstock
CRLCharles River Laboratories International Inc
$149.45-1.61%
Edge Rankings
Momentum
17.42
Growth
28.18
Quality
15.46
Value
16.14
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
